Overview
Physicians’ Education Resource®, LLC (PER®), is pleased to present the 2026 International Symposium of Gastrointestinal Oncology® (ISGIO), a 2-day, multidisciplinary educational conference dedicated to presenting and discussing the latest advances in the broad field of gastrointestinal (GI) cancer research, as well as critical issues relevant to the care of persons with GI cancer.
Management of GI malignancies has evolved across all disciplines, from screening to prognostication to treatment approaches of all modalities. However, many patients do not fall neatly into guideline-based treatment, and the volume of clinical trial data makes it difficult to parse findings that should inform treatment.
This highly engaging conference brings together world-renowned experts from different disciplines to educate clinicians using a combination of case-based learning, debates, and panel discussions. This dynamic, multi-format program is designed to be a comprehensive review of the emerging treatment landscape for GI cancers, with the goal of elucidating the complex array of recent studies that should inform clinician practice.
Learning Objectives
Upon completion of this activity, learners will be better able to:
- Integrate biomarker testing results to individualize treatment selection for patients with GI cancers
- Evaluate the latest efficacy and safety data for newly approved therapies, novel combinations, and emerging agents in GI cancers
- Develop personalized treatment plans for patients with GI cancers based on current evidence and clinical guidelines
- Incorporate new clinical data to effectively sequence available therapies and optimize patient outcomes
- Apply evidence-based strategies to proactively monitor, prevent, and manage treatment-related adverse events in patients receiving novel therapies and combination regimens
Program Co-Chairs
Tanios Bekaii-Saab, MD; Eileen M. O’Reilly, MD, FASCO
To view full profile, click on the Program Co-Chairs tab above.
Tanios Bekaii-Saab, MD
David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research
Professor, Mayo Clinic College of Medicine and Science
Program Leader, Advanced Clinical Trials and Translational Science
Leader, Gastrointestinal Disease Group Mayo Clinic Cancer Center (All Regions)
Chair and Consultant, Division of Hematology and Medical Oncology, Mayo Clinic in Arizona and the Southwest Region
Phoenix, AZ
Eileen M. O’Reilly, MD, FASCO
Professor of Medicine Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center
New York, NY
Click the button below to view all faculty presenters.
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 12.75 Contact Hours.
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 12.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.